PT1252163E - Derivados de pirrole substituidos com 4-piridil- e 2,4-pirimidinilo e a sua utilizacao em farmacia - Google Patents
Derivados de pirrole substituidos com 4-piridil- e 2,4-pirimidinilo e a sua utilizacao em farmaciaInfo
- Publication number
- PT1252163E PT1252163E PT01902370T PT01902370T PT1252163E PT 1252163 E PT1252163 E PT 1252163E PT 01902370 T PT01902370 T PT 01902370T PT 01902370 T PT01902370 T PT 01902370T PT 1252163 E PT1252163 E PT 1252163E
- Authority
- PT
- Portugal
- Prior art keywords
- pyrimidyl
- pyridyl
- alkyl
- inhibitor
- 1beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10004157A DE10004157A1 (de) | 2000-02-01 | 2000-02-01 | 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1252163E true PT1252163E (pt) | 2004-02-27 |
Family
ID=7629335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT01902370T PT1252163E (pt) | 2000-02-01 | 2001-01-31 | Derivados de pirrole substituidos com 4-piridil- e 2,4-pirimidinilo e a sua utilizacao em farmacia |
Country Status (16)
Country | Link |
---|---|
US (1) | US6867211B2 (pt) |
EP (1) | EP1252163B1 (pt) |
JP (1) | JP2003525227A (pt) |
KR (1) | KR20030005176A (pt) |
CN (1) | CN1206230C (pt) |
AT (1) | ATE250608T1 (pt) |
AU (1) | AU2001230219A1 (pt) |
CA (1) | CA2398111C (pt) |
DE (2) | DE10004157A1 (pt) |
DK (1) | DK1252163T3 (pt) |
ES (1) | ES2208548T3 (pt) |
MX (1) | MXPA02007403A (pt) |
NO (1) | NO323246B1 (pt) |
PT (1) | PT1252163E (pt) |
TR (1) | TR200301898T4 (pt) |
WO (1) | WO2001057042A2 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10001166A1 (de) | 2000-01-13 | 2001-07-19 | Merckle Gmbh | Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung |
NZ531226A (en) | 2001-08-30 | 2006-07-28 | Merckle Gmbh | Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration |
US6730668B2 (en) * | 2001-09-20 | 2004-05-04 | The Procter & Gamble Company | 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
US7087615B2 (en) | 2001-09-20 | 2006-08-08 | The Procter & Gamble Company | 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia |
US6849627B2 (en) | 2001-09-20 | 2005-02-01 | The Procter & Gamble Company | 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
US20050043331A1 (en) * | 2002-09-27 | 2005-02-24 | Bullington James L. | Substituted 3-(2,5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases |
ATE426605T1 (de) * | 2003-06-12 | 2009-04-15 | Merck & Co Inc | Inhibitoren von mitotischem kinesin |
GB0520958D0 (en) * | 2005-10-14 | 2005-11-23 | Cyclacel Ltd | Compound |
EP1884239A1 (en) * | 2006-07-28 | 2008-02-06 | Merckle Gmbh | Annellated pyrrole compounds for cancer management |
GB0816759D0 (en) * | 2008-09-12 | 2008-10-22 | Selcia Ltd | Compounds |
US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3920672A (en) | 1974-08-22 | 1975-11-18 | Syntex Inc | Thiacycl (2.2.2.)azine carboxylic acids |
JPS56100784A (en) | 1980-01-16 | 1981-08-12 | Yoshitomi Pharmaceut Ind Ltd | Indolizine derivative |
US4536512A (en) | 1982-10-08 | 1985-08-20 | Merck & Co., Inc. | 5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2,3-dihydro-1H-pyrrolizine-1-alkanoic or carboxylic acids and use thereof as anti-inflammatory and analgesic agents |
FR2539417A1 (fr) | 1983-01-13 | 1984-07-20 | Rhone Poulenc Sante | Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent |
DD216021A5 (de) * | 1983-01-13 | 1984-11-28 | Rhone Poulenc Sante | Verfahren zur herstellung eines neuen pyrrolderivates |
US4560699A (en) | 1983-01-17 | 1985-12-24 | Syntex (U.S.A.) Inc. | 5-(4-Vinylbenzoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof and use as analgesics and anti-inflammatories |
FR2557111B1 (fr) | 1983-12-21 | 1986-04-11 | Rhone Poulenc Sante | Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent |
US4719218A (en) | 1985-12-12 | 1988-01-12 | Smithkline Beckman Corporation | Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor |
US4873340A (en) * | 1986-05-29 | 1989-10-10 | Syntex (U.S.A.) Inc. | Process for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-A]pyrrole-1,1-dicarboxylates |
FR2617484B1 (fr) | 1987-07-02 | 1989-10-20 | Rhone Poulenc Sante | Procede de preparation de l'acide (pyridyl-3)-3 1h-3h-pyrrolo (1,2-c) thiazolecarboxylique-7 dextrogyre |
DE3732135A1 (de) | 1987-09-24 | 1989-04-13 | Deutsche Forsch Luft Raumfahrt | Entladungskanal fuer hochleistungslaser |
US5260451A (en) | 1989-05-11 | 1993-11-09 | Merckle Gmbh | Substituted pyrrole compounds and use thereof in pharmaceutical compositions |
DE3915450A1 (de) * | 1989-05-11 | 1990-11-15 | Gerd Prof Dr Dannhardt | Substituierte pyrrolverbindungen und deren anwendung in der pharmazie |
WO1991000093A1 (en) | 1989-06-26 | 1991-01-10 | The Research Foundation Of State University Of New York | Bis-acyloxymethyl derivatives |
US5459152A (en) * | 1991-07-17 | 1995-10-17 | Abbott Laboratories | Platelet activating factor antagonists |
JPH05289267A (ja) | 1992-04-07 | 1993-11-05 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
EP0608133B1 (en) | 1993-01-21 | 1999-07-07 | Konica Corporation | A silver halide color photographic material |
DE4419246A1 (de) * | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie |
DE4419247A1 (de) * | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie |
DE4419315A1 (de) * | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie |
US5552422A (en) | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
DE19845446A1 (de) | 1998-10-02 | 2000-04-06 | Merckle Gmbh | Antiinflammatorische Oxo- und Hydroxyderivate von Pyrrolizinen und deren Verwendung in der Pharmazie |
WO2001000332A1 (en) | 1999-06-24 | 2001-01-04 | Varco I/P Inc. | A screen, a panel for a screen, a shale shaker and a method of screening |
US7640571B1 (en) | 1999-07-15 | 2009-12-29 | General Instrument Corporation | Method and apparatus for preventing disruptions in set-top terminal function due to the download of updated programming or data to the set-top terminal |
SK286082B6 (sk) | 1999-11-23 | 2008-03-05 | Merckle Gmbh | Protizápalové oxo- a hydroxyderiváty pyrolizínov a ich použitie vo farmácii |
DE10001166A1 (de) * | 2000-01-13 | 2001-07-19 | Merckle Gmbh | Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung |
-
2000
- 2000-02-01 DE DE10004157A patent/DE10004157A1/de not_active Withdrawn
-
2001
- 2001-01-31 JP JP2001557873A patent/JP2003525227A/ja active Pending
- 2001-01-31 CN CNB018044298A patent/CN1206230C/zh not_active Expired - Fee Related
- 2001-01-31 TR TR2003/01898T patent/TR200301898T4/xx unknown
- 2001-01-31 ES ES01902370T patent/ES2208548T3/es not_active Expired - Lifetime
- 2001-01-31 CA CA002398111A patent/CA2398111C/en not_active Expired - Fee Related
- 2001-01-31 AU AU2001230219A patent/AU2001230219A1/en not_active Abandoned
- 2001-01-31 US US10/182,579 patent/US6867211B2/en not_active Expired - Fee Related
- 2001-01-31 EP EP01902370A patent/EP1252163B1/de not_active Expired - Lifetime
- 2001-01-31 AT AT01902370T patent/ATE250608T1/de not_active IP Right Cessation
- 2001-01-31 PT PT01902370T patent/PT1252163E/pt unknown
- 2001-01-31 MX MXPA02007403A patent/MXPA02007403A/es active IP Right Grant
- 2001-01-31 DK DK01902370T patent/DK1252163T3/da active
- 2001-01-31 DE DE50100678T patent/DE50100678D1/de not_active Expired - Fee Related
- 2001-01-31 KR KR1020027009854A patent/KR20030005176A/ko not_active Application Discontinuation
- 2001-01-31 WO PCT/EP2001/001011 patent/WO2001057042A2/de active IP Right Grant
-
2002
- 2002-07-31 NO NO20023634A patent/NO323246B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA02007403A (es) | 2004-04-05 |
DE10004157A1 (de) | 2001-08-02 |
DE50100678D1 (de) | 2003-10-30 |
US6867211B2 (en) | 2005-03-15 |
ATE250608T1 (de) | 2003-10-15 |
CN1396923A (zh) | 2003-02-12 |
WO2001057042A3 (de) | 2001-12-27 |
EP1252163A2 (de) | 2002-10-30 |
NO20023634L (no) | 2002-09-25 |
AU2001230219A1 (en) | 2001-08-14 |
ES2208548T3 (es) | 2004-06-16 |
JP2003525227A (ja) | 2003-08-26 |
WO2001057042A2 (de) | 2001-08-09 |
EP1252163B1 (de) | 2003-09-24 |
CN1206230C (zh) | 2005-06-15 |
KR20030005176A (ko) | 2003-01-17 |
US20030153558A1 (en) | 2003-08-14 |
CA2398111C (en) | 2008-08-12 |
CA2398111A1 (en) | 2001-08-09 |
TR200301898T4 (tr) | 2004-01-21 |
DK1252163T3 (da) | 2004-01-19 |
NO323246B1 (no) | 2007-02-12 |
NO20023634D0 (no) | 2002-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1252163E (pt) | Derivados de pirrole substituidos com 4-piridil- e 2,4-pirimidinilo e a sua utilizacao em farmacia | |
DK1175214T3 (da) | Cyclooxygenase-2-hæmmer-kompositioner med hurtig indtræden af terapeutisk virkning | |
DK2295052T3 (da) | Anvendelse af ritonavir til forbedring af farmakokinetikken af lægemidler, der metaboliseres af cytochrom P450 | |
CL2008003067A1 (es) | Compuesto 2-[3-(2,2-difluoro-benzo[1,3]dioxol-5-ilamino)-5-(2,6-dimetil-piridin-4-il)-[1,2,4]triazol-1-il]-n-etil-acetamida, modulador de receptores nicotinicos alfa-7; proceso de preparacion; composicion farmaceutica y su proceso de preparacion; y su uso en el tratamiento de trastornos psicoticos, intelectuales, inflamatorios. | |
DE60223254D1 (de) | Verzögert freisetzende formulierungen von oxymorphon | |
JP2006502236A5 (pt) | ||
IL158589A (en) | Carboxylic acid substituted oxazole derivatives, process for their manufacture, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment and prophylaxis of diseases which are modulated by ppar-alpha and -gamma activators | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
NZ614151A (en) | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
MXPA03005464A (es) | Agentes antivirales. | |
RS20100338A (en) | FLUOROSUPSTITUTIONED CYCLOALCANOINDOLES AND THEIR USE AS AN ANTAGONISTS OF PROSTAGLAND D2 RECEPTORS | |
ECSP055915A (es) | Combinación farmacéutica para la prevención o la terapia de enfermedades cardiovasculares, cardiopulmonares, pulmonares o renales | |
BRPI0309918B8 (pt) | aplicação aperfeiçoada para ácidos de lúpulo como agentes antimicrobianos | |
ATE497766T1 (de) | Verringerung von schwindel, einer nebenwirkung im zusammenhang mit einer pirfenidon-therapie | |
EP1690539A3 (de) | Tiotropiumsalze zur Behandlung von inflammatorischen Erkrankungen | |
NZ594369A (en) | Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases | |
AU2001261986A1 (en) | Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders | |
MY133107A (en) | Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia | |
AU2001233757A1 (en) | Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases | |
CA2504872A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
DE60226225D1 (de) | Phtalazine derivate mit angiogenesis inhibierender wirkung | |
MXPA04000775A (es) | Uso novedoso del 2 -[5-(4-fluorofenil) -3-piridilmetilamino-metil] -cromano y sus sales fisiologicamente aceptables. | |
SI2316831T1 (sl) | 2-(morfolin-4-il)pirimidini kot inhibitorji fosfotidilinozitol (PI) 3-kinaze in njihova uporaba pri zdravljenju raka | |
MXPA03003980A (es) | Uso de melagatran para la elaboracion de un medicamento para el tratamiento de transtornos isquemicos. | |
IT1320192B1 (it) | Composizione terapeutica per la cura della psoriasi. |